0.9746
price down icon2.05%   -0.0204
after-market 시간 외 거래: .99 0.0154 +1.58%
loading
전일 마감가:
$0.995
열려 있는:
$0.99
하루 거래량:
358.53K
Relative Volume:
0.78
시가총액:
$41.60M
수익:
-
순이익/손실:
$-35.58M
주가수익비율:
-0.3678
EPS:
-2.65
순현금흐름:
$-42.82M
1주 성능:
-0.93%
1개월 성능:
-2.54%
6개월 성능:
-44.94%
1년 성능:
-11.00%
1일 변동 폭
Value
$0.97
$0.99
1주일 범위
Value
$0.97
$1.0598
52주 변동 폭
Value
$0.808
$3.02

Iterum Therapeutics Plc Stock (ITRM) Company Profile

Name
명칭
Iterum Therapeutics Plc
Name
전화
(872) 225-6077
Name
주소
3 DUBLIN LANDINGS, DUBLIN 1
Name
직원
9
Name
트위터
Name
다음 수익 날짜
2025-02-07
Name
최신 SEC 제출 서류
Name
ITRM's Discussions on Twitter

ITRM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ITRM
Iterum Therapeutics Plc
0.9746 41.60M 0 -35.58M -42.82M -2.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-05-28 업그레이드 Gabelli & Co Sell → Hold
2021-03-15 업그레이드 H.C. Wainwright Neutral → Buy
2020-06-02 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2020-01-21 다운그레이드 Gabelli & Co Buy → Sell
2019-12-11 다운그레이드 SVB Leerink Outperform → Mkt Perform
2019-06-21 개시 H.C. Wainwright Buy
모두보기

Iterum Therapeutics Plc 주식(ITRM)의 최신 뉴스

pulisher
Jun 17, 2025

Transcript : Iterum Therapeutics plcSpecial Call - MarketScreener

Jun 17, 2025
pulisher
Jun 14, 2025

Research Analysts Set Expectations for ITRM FY2026 Earnings - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Invests $45,000 in Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships - pharmaphorum

Jun 13, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Acquires Shares of 21,207 Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics (ITRM) Partners with EVERSANA for U.S. Launc - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics announces partnership with EVERSANA - PharmaLive

Jun 11, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics inks deal for ORLYNVAH commercialization By Investing.com - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics inks deal for ORLYNVAH commercialization - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics Announces Partnership for Commercialization Services - Yahoo Finance

Jun 11, 2025
pulisher
May 19, 2025

Pfizer grants Iterum payment extension for FDA-approved antibiotic By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

Pfizer grants Iterum payment extension for FDA-approved antibiotic - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Iterum Therapeutics Announces Extension of Term of Promissory No - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Iterum Therapeutics (ITRM) Extends $20M Payment Deadline with Pf - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Iterum Therapeutics Announces Extension of Term of Promissory Note | ITRM Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Iterum Therapeutics Announces Extension of Term of Promissory Note - The Manila Times

May 19, 2025
pulisher
May 19, 2025

Iterum Therapeutics Announces Extension of $20 Million Regulatory Milestone Payment Deadline with Pfizer to 2029 - Nasdaq

May 19, 2025
pulisher
May 19, 2025

Iterum Gains 3-Year Extension on $20M Pfizer Payment, Strengthens ORLYNVAH Launch Strategy - Stock Titan

May 19, 2025
pulisher
May 19, 2025

Iterum targets ORLYNVAH US launch by Q4 2025 while extending cash runway into 2026 - MSN

May 19, 2025
pulisher
May 16, 2025

When Will Iterum Therapeutics plc (NASDAQ:ITRM) Become Profitable? - simplywall.st

May 16, 2025
pulisher
May 14, 2025

Iterum Therapeutics plc (NASDAQ:ITRM) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Iterum Therapeutics PLC (ITRM) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Iterum Therapeutics PLC (ITRM) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Stability Amidst Market Challenges - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Iterum Therapeutics PLC (ITRM) Q1 2025 Earnings Call Highlights: - GuruFocus

May 14, 2025
pulisher
May 13, 2025

ITRM Plans Fourth-Quarter Launch for ORLYNVAH in UTI Treatment | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Iterum Therapeutics (ITRM) Projects Adequate Funding Until 2026 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Iterum Therapeutics plc SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Iterum Therapeutics Reports First Quarter 2025 Financial Results - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Transcript : Iterum Therapeutics plc, Q1 2025 Earnings Call, May 13, 2025 - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

Q1 Earnings Estimate for ITRM Issued By HC Wainwright - Defense World

May 12, 2025
pulisher
May 11, 2025

Iterum Therapeutics’ (ITRM) Buy Rating Reiterated at HC Wainwright - Defense World

May 11, 2025
pulisher
May 10, 2025

Iterum Therapeutics plc (NASDAQ:ITRM): When Will It Breakeven? - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Iterum Therapeutics (ITRM) to Release Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Iterum Therapeutics (ITRM) Receives Buy Rating from HC Wainwrigh - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Iterum Therapeutics (ITRM) Receives Buy Rating from Analyst | IT - GuruFocus

May 09, 2025
pulisher
May 06, 2025

Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

Iterum Therapeutics Earnings Coming May 13: Next-Gen Antibiotics Developer Sets Q1 2025 Update - Stock Titan

May 06, 2025
pulisher
May 02, 2025

Renaissance Technologies LLC Purchases Shares of 438,816 Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World

May 02, 2025
pulisher
May 01, 2025

Check Out Iterum Therapeutics Plc (ITRM)’s Trade Data Rather Than the Analysts’ Views - Sete News

May 01, 2025
pulisher
May 01, 2025

Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares - The Manila Times

May 01, 2025
pulisher
Apr 30, 2025

Iterum Therapeutics Raises $5M from Single Investor: Major Push for Antibiotic Commercialization - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

Iterum Therapeutics Plc: Rising -64.90% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Iterum Therapeutics Plc (ITRM) Becoming More Attractive for Investors - knoxdaily.com

Apr 30, 2025
pulisher
Apr 29, 2025

Iterum Therapeutics (ITRM) Secures $5 Million in Direct Offering - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Evaluating ITRM’s financial ratios for a profitable investment - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Iterum Therapeutics secures $5 million in direct offering - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Iterum Therapeutics Announces $5 Million Registered Direct Offering Of Ordinary Shares - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Iterum Therapeutics plc Announces Definitive Agreement for $5 Million Registered Direct Offering of Shares - Nasdaq

Apr 29, 2025
pulisher
Apr 29, 2025

Iterum Therapeutics Secures Critical $5M Funding: ORLYNVAH Drug Launch Plans Accelerate - Stock Titan

Apr 29, 2025
pulisher
Apr 24, 2025

ITRM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Iterum Therapeutics Plc (NASDAQ:ITRM) Shares Surged 24.11% In A Week – But Can It Maintain Its Gains? - Marketing Sentinel

Apr 24, 2025

Iterum Therapeutics Plc (ITRM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):